DE2752725C2 - - Google Patents

Info

Publication number
DE2752725C2
DE2752725C2 DE2752725A DE2752725A DE2752725C2 DE 2752725 C2 DE2752725 C2 DE 2752725C2 DE 2752725 A DE2752725 A DE 2752725A DE 2752725 A DE2752725 A DE 2752725A DE 2752725 C2 DE2752725 C2 DE 2752725C2
Authority
DE
Germany
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2752725A
Other languages
German (de)
Other versions
DE2752725A1 (en
Inventor
Adolf Von Sharon Ontario Ca Seefried
Joong Hwan Mississauga Ontario Ca Chun
Hildegarde M.G. Thornhill Ontario Ca Macmorine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Original Assignee
Connaught Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connaught Laboratories Ltd filed Critical Connaught Laboratories Ltd
Publication of DE2752725A1 publication Critical patent/DE2752725A1/en
Application granted granted Critical
Publication of DE2752725C2 publication Critical patent/DE2752725C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE19772752725 1976-11-29 1977-11-25 POLIOMYELITIS VACCINE Granted DE2752725A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA266,768A CA1067406A (en) 1976-11-29 1976-11-29 Stabilized oral poliovaccine and stabilizing medium therefor

Publications (2)

Publication Number Publication Date
DE2752725A1 DE2752725A1 (en) 1978-06-15
DE2752725C2 true DE2752725C2 (en) 1987-02-12

Family

ID=4107389

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19772747662 Pending DE2747662A1 (en) 1976-11-29 1977-10-24 POLIOMYELITIS VACCINE
DE19772752725 Granted DE2752725A1 (en) 1976-11-29 1977-11-25 POLIOMYELITIS VACCINE

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19772747662 Pending DE2747662A1 (en) 1976-11-29 1977-10-24 POLIOMYELITIS VACCINE

Country Status (10)

Country Link
AT (1) AT351161B (en)
BE (1) BE861265A (en)
CA (1) CA1067406A (en)
DE (2) DE2747662A1 (en)
DK (1) DK145175C (en)
FI (1) FI57534C (en)
FR (1) FR2371927A1 (en)
NL (1) NL7713087A (en)
NO (1) NO773378L (en)
SE (1) SE426440B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252792A (en) 1979-09-21 1981-02-24 Douglas Industries, Inc. Injectable rabies vaccine composition and method for preparing same
EP0049296B1 (en) * 1980-10-02 1985-03-27 Schering Corporation Injectable rabies vaccine composition and method for preparing same
NL8102740A (en) * 1981-06-05 1983-01-03 Nederlanden Staat VIRUS VACCINES AND METHOD FOR THE PREPARATION THEREOF.
US5360736A (en) * 1992-06-04 1994-11-01 Merck & Co., Inc. Process for attenuated varicella zoster virus vaccine production

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665076A (en) * 1963-12-23 1965-12-08

Also Published As

Publication number Publication date
CA1067406A (en) 1979-12-04
FR2371927B1 (en) 1981-06-19
ATA850077A (en) 1978-12-15
FR2371927A1 (en) 1978-06-23
NO773378L (en) 1978-05-30
BE861265A (en) 1978-03-16
AT351161B (en) 1979-07-10
SE7712473L (en) 1978-05-30
SE426440B (en) 1983-01-24
FI57534B (en) 1980-05-30
FI57534C (en) 1980-09-10
DK145175B (en) 1982-09-27
NL7713087A (en) 1978-05-31
DE2752725A1 (en) 1978-06-15
FI773015A (en) 1978-05-30
DK526477A (en) 1978-05-30
DK145175C (en) 1983-02-28
DE2747662A1 (en) 1978-06-01

Similar Documents

Publication Publication Date Title
FR2361374B1 (en)
JPS579159B2 (en)
FR2371927B1 (en)
FR2369139B1 (en)
JPS5526447Y2 (en)
JPS5615500B2 (en)
JPS5313931U (en)
JPS5736774Y2 (en)
JPS5733277Y2 (en)
FR2351919B1 (en)
JPS5440371B2 (en)
JPS52136915U (en)
JPS52149545U (en)
JPS52109040U (en)
CS177790B1 (en)
JPS5317141U (en)
JPS5323394U (en)
DD126114A1 (en)
CH612137A5 (en)
DD126236A1 (en)
DD126224A1 (en)
DD126190A1 (en)
DD126168A1 (en)
CH598564A5 (en)
DD126099A1 (en)

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee